NIHR partners with other global health research organisations to support high quality research projects and career development opportunities for researchers. We partner with organisations in the UK and worldwide, and participate in multi-funder initiatives in global health research.
UK partners
| Partner | Partnership aim | Funding programme(s) |
|---|---|---|
| Economic and Social Research Council | To investigate behaviour within and beyond the healthcare setting (theme four of the cross-council initiative on AMR) and how the behaviour of public, professionals and organisations impacts on AMR. | AMR cross-council initiative: behaviour within and beyond the healthcare setting |
| Engineering and Physical Sciences Research Council |
To support research on innovative healthcare technologies to tackle the challenges faced by LMICs, either:
|
Diagnostics, prosthetics and orthotics to tackle health challenges in developing countries |
| Medical Research Council | To support applied research - seeking practical solutions to health challenges from late stage intervention development onwards - that will be of direct and primary benefit to the health of vulnerable populations living in low and middle income countries (LMICs). | |
| To support interdisciplinary and focused research at international levels to identify the burden and primary drivers of antimicrobial resistance (AMR), and specifically antibacterial resistance in LMICs. | AMR in a global context | |
| Royal Society of Tropical Medicine and Hygiene (RSTMH) | To support research and capacity development for early career researchers based in LMICs that will benefit patients and the public in LMICs. | Small grants for early career researchers in tropical medicine or global health |
| Wellcome | To fund masters, postdoctoral and early career researchers from LMICs and the UK to carry out high quality research into an area of health priority for LMICs. | NIHR-Wellcome Global Health Research Partnership |
International partners
| Partner | Partnership aim | Funding programme(s) |
|---|---|---|
| African Academy of Sciences (AAS) | To develop the world’s first international standard for good financial practice in grant management. | Good Financial Grants Practice (GFGP) |
| European & Developing Countries Clinical Trials Partnership (EDCTP) | To support collaborative research that accelerates the clinical development of new or improved interventions to prevent or treat poverty related diseases, as well as emerging and re-emerging infectious diseases affecting sub-Saharan Africa. NIHR has supported research calls in 2016, 2017 and 2018, in addition to programme management activities associated with enhancing the wider programme. | Research and clinical management of patients in poverty related disease (PRD) epidemics in sub-Saharan Africa |
| Clinical trials and operational research studies to optimise the use of products for poverty-related diseases in mothers, new-borns, children and adolescents | ||
| Strategic actions supporting large-scale clinical trials | ||
| Clinical trials to reduce health inequities in pregnant women, newborns and children | ||
| Diagnostic tools for poverty-related diseases challenge | ||
|
Vaccines for diarrhoeal diseases or lower respiratory tract infections |
||
| Grand Challenges Canada (GCC) | To fund high impact innovations that improve treatments and/or expand access to care for people living with or are at risk of mental health disorders, with a focus on the mental health needs of young people in LMICs. | Global Mental Health - seed and transition to scale research |
| Special Programme for Research and Training in Tropical Diseases (TDR) | To build sustainable operational research capacity to generate and use evidence on the emergence, spread and health impact of AMR, in order to limit this public health problem. | Antimicrobial Resistance Structured Operational Research and Training Initiative (AMR SORT IT) |
Multi-funder initiatives
| Initiative | Aim | Partners | Funding programme(s) |
|---|---|---|---|
| Global Alliance for Chronic Diseases (GACD) |
To support research that addresses the prevention and treatment of chronic non-communicable diseases, on a global scale. | Associate Members | Primary and/or secondary prevention of cancer |
| Prevention and management of mental disorders | |||
| Scaling-up of evidence-based interventions at the population level for the prevention and/or management of hypertension and/or diabetes Common risk factors |
|||
| Joint Global Health Trials (JGHT) initiative | To generate new knowledge to contribute to improving health in LMICs, focusing on research that yields implementable results and addresses the major causes of mortality or morbidity in LMICs. |
DFID (now Foreign, Commonwealth & Development Office), Medical Research Council*, Wellcome |
|
| Research for Health in Humanitarian Crises (R2HC) | To develop more effective responses to humanitarian challenges by providing significant funding for high quality research on the effectiveness of health interventions in humanitarian crises. |
DFID (now Foreign, Commonwealth & Development Office), Wellcome, ELRHA* |
Research to support COVID-19 response in humanitarian settings |
| World Bank Global Road Safety Facility (GRSF) | To address the growing public health crisis of road traffic deaths and injuries in LMICs through supporting the scale-up of scientific, technological and managerial capacities to effectively manage road safety. | DFID (now Foreign, Commonwealth & Development Office), World Bank* | Road Safety Grant Program |
*Delivery partner.
Multi-funder initiatives - Product Development Partnerships
| Initiative | Summary | Funding programme(s) |
|---|---|---|
| Coalition on Epidemic Preparedness and Innovation (CEPI) | A global partnership aiming to stimulate and accelerate the development of vaccines against emerging infectious diseases and enable access to these vaccines for people during outbreaks. | Research to develop a wide range of vaccine candidates and platform technologies against emerging infectious diseases including COVID-19< |
| Foundation for Innovative New Diagnostics (FIND) | A global non-profit product development partnership that aims to develop, evaluate and deliver high quality affordable diagnostic tests for poverty-related diseases. | |
| Global Antibiotic Research and Development Partnership (GARDP) | A research and development initiative addressing global public health needs by developing, delivering and assuring sustainable access of new or improved antibiotic treatments. | Transforming care of babies with sepsis |
| Medicines for Malaria Ventures (MMV) | An initiative to reduce the burden of malaria in disease-endemic countries by discovering, developing and delivering new, effective and affordable antimalarial drugs. | |
| TB Alliance | A not-for-profit organisation dedicated to the discovery, development and delivery of better, faster-acting and affordable tuberculosis drugs that are available to those who need them. | |